The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to
the Securities and Exchange Commission (SEC)
by insider Milligan John C.k. Iv since year 2005.
The trader's CIK number is 1532230.
At the time of this reporting, Milligan John C.k. Iv is the President/Secretary of Therapeuticsmd, Inc. .
(stock ticker symbol TXMD).
See this page for all insider trading activities at Therapeuticsmd, Inc. .
| Trade Date | Symbol | Company Name (Issuer) | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|---|
| 2018-12-17 | TXMD | Therapeuticsmd, Inc. | Option Ex | 129,000 | .10 | 13,158 |
| 2018-12-18 | TXMD | Therapeuticsmd, Inc. | Option Ex | 129,127 | .10 | 13,170 |
| 2018-12-17 | TXMD | Therapeuticsmd, Inc. | Sale | 129,000 | 3.75 | 483,750 |
| 2018-12-18 | TXMD | Therapeuticsmd, Inc. | Sale | 129,127 | 3.64 | 469,634 |
| 2018-12-06 | TXMD | Therapeuticsmd, Inc. | Sale | 129,000 | 4.57 | 589,530 |
| 2018-12-06 | TXMD | Therapeuticsmd, Inc. | Option Ex | 129,000 | .10 | 13,158 |
| 2018-12-04 | TXMD | Therapeuticsmd, Inc. | Sale | 129,000 | 4.98 | 642,162 |
| 2018-12-04 | TXMD | Therapeuticsmd, Inc. | Option Ex | 129,000 | .10 | 13,158 |
| 2018-11-29 | TXMD | Therapeuticsmd, Inc. | Sale | 129,128 | 5.03 | 650,030 |
| 2018-11-28 | TXMD | Therapeuticsmd, Inc. | Sale | 129,000 | 4.89 | 630,294 |
| 2018-11-29 | TXMD | Therapeuticsmd, Inc. | Option Ex | 129,128 | .10 | 13,171 |
| 2018-11-28 | TXMD | Therapeuticsmd, Inc. | Option Ex | 129,000 | .10 | 13,158 |
| 2018-11-15 | TXMD | Therapeuticsmd, Inc. | Sale | 129,000 | 4.99 | 643,581 |
| 2018-11-14 | TXMD | Therapeuticsmd, Inc. | Sale | 129,000 | 4.82 | 621,651 |
| 2018-11-15 | TXMD | Therapeuticsmd, Inc. | Option Ex | 129,000 | .10 | 13,158 |
| 2018-11-14 | TXMD | Therapeuticsmd, Inc. | Option Ex | 129,000 | .10 | 13,158 |
| 2018-10-23 | TXMD | Therapeuticsmd, Inc. | Option Ex | 125,000 | .10 | 12,750 |
| 2018-10-24 | TXMD | Therapeuticsmd, Inc. | Option Ex | 125,000 | .10 | 12,750 |
| 2018-10-23 | TXMD | Therapeuticsmd, Inc. | Sale | 125,000 | 5.33 | 666,250 |
| 2018-10-24 | TXMD | Therapeuticsmd, Inc. | Sale | 125,000 | 5.37 | 671,250 |
| 2018-10-09 | TXMD | Therapeuticsmd, Inc. | Option Ex | 125,000 | .10 | 12,750 |
| 2018-10-10 | TXMD | Therapeuticsmd, Inc. | Option Ex | 125,000 | .10 | 12,750 |
| 2018-10-09 | TXMD | Therapeuticsmd, Inc. | Sale | 125,000 | 5.95 | 743,125 |
| 2018-10-10 | TXMD | Therapeuticsmd, Inc. | Sale | 125,000 | 5.76 | 719,625 |
| 2018-09-25 | TXMD | Therapeuticsmd, Inc. | Sale | 125,000 | 6.78 | 847,250 |
| 2018-09-26 | TXMD | Therapeuticsmd, Inc. | Option Ex | 125,000 | .10 | 12,750 |
| 2018-09-25 | TXMD | Therapeuticsmd, Inc. | Option Ex | 125,000 | .10 | 12,750 |
| 2018-09-26 | TXMD | Therapeuticsmd, Inc. | Sale | 125,000 | 6.78 | 847,000 |
| 2018-09-11 | TXMD | Therapeuticsmd, Inc. | Sale | 125,000 | 6.13 | 765,750 |
| 2018-09-10 | TXMD | Therapeuticsmd, Inc. | Sale | 125,000 | 6.07 | 758,125 |
| 2018-09-11 | TXMD | Therapeuticsmd, Inc. | Option Ex | 125,000 | .10 | 12,750 |
| 2018-09-10 | TXMD | Therapeuticsmd, Inc. | Option Ex | 125,000 | .10 | 12,750 |
| 2014-05-12 | TXMD | Therapeuticsmd, Inc. | Option Ex | 20,000 | .10 | 2,039 |
| 2014-03-26 | TXMD | Therapeuticsmd, Inc. | Sale | 353,412 | 6.70 | 2,366,800 |
| 2014-02-26 | TXMD | Therapeuticsmd, Inc. | Sale | 8,400 | 6.53 | 54,843 |
| 2014-02-25 | TXMD | Therapeuticsmd, Inc. | Sale | 8,300 | 6.16 | 51,119 |
| 2014-02-24 | TXMD | Therapeuticsmd, Inc. | Sale | 8,300 | 6.23 | 51,733 |
| 2014-01-28 | TXMD | Therapeuticsmd, Inc. | Sale | 8,300 | 5.94 | 49,318 |
| 2014-01-29 | TXMD | Therapeuticsmd, Inc. | Sale | 8,300 | 6.03 | 50,049 |
| 2014-01-30 | TXMD | Therapeuticsmd, Inc. | Sale | 8,400 | 6.49 | 54,549 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Milligan John C.k. Iv (President/Secretary of Therapeuticsmd, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.